Drug
VAP-cyclo protocol clinical trials
Keep track of what changes. Save the VAP-cyclo protocol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- CHOP regimen
- 11
Studies by the year they started
12 studies that test it; most in 1997 (2)
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1997 | 2 |
| 1998 | 1 |
| 1999 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 12
Mingzhi Zhang (3) · European Organisation for Research and Treatment of Cancer - EORTC (2) · University of Nebraska (1) · M.D. Anderson Cancer Center (1) · Lymphoma Trials Office (1) · Eastern Cooperative Oncology Group (1) · SWOG Cancer Research Network (1) · Swiss Group for Clinical Cancer Research (1)
Often tested with
Tested in the same studies.
Cyclophosphamide (2) · Etoposide (2) · Rituximab (1) · Bleomycin (1) · Cisplatin (1) · Cytarabine (1) · Idarubicin (1) · Ifosfamide (1)
Studies
Open first, then newest update. How each study uses VAP-cyclo protocol is read from its arms, and is right about nine times in ten.
Testing it · 12
- Go-CHOP as the Frontline Therapy for PTCLRecruitingPhase 2Henan Cancer HospitalNCT05963347Written as CHOP Regimen
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's LymphomaCompletedPhase 3University of NebraskaNCT00004112Written as CHOP regimen
- Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's LymphomaCompletedPhase 3M.D. Anderson Cancer CenterNCT00002565Written as CHOP regimen
- Treatment of Elderly Patients With Diffuse Large B-cell LymphomaStatus unknownPhase 4Mingzhi ZhangNCT03513601Written as (R)-CHOP regimen
- Treatment of Peripheral T-cell LymphomaCompletedPhase 4Mingzhi ZhangNCT01664975Written as CHOP regimen
- Treatment of Diffuse Large B Cell LymphomaStatus unknownPhase 4Mingzhi ZhangNCT01949818Written as CHOP regimen
- Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's LymphomaCompletedPhase 3Lymphoma Trials OfficeNCT00005867Written as CHOP regimen
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's LymphomaCompletedPhase 3Eastern Cooperative Oncology GroupNCT00003150Written as CHOP regimen
- S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaCompletedPhase 2SWOG Cancer Research NetworkNCT00003784Written as CHOP regimen
- Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's LymphomaCompletedPhase 2European Organisation for Research and Treatment of Cancer - EORTCNCT00079261Written as CHOP regimen
- Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's LymphomaTerminatedPhase 2/3European Organisation for Research and Treatment of Cancer - EORTCNCT00060385Written as CHOP regimen
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's LymphomaCompletedPhase 3Swiss Group for Clinical Cancer ResearchNCT00003215Written as CHOP regimen
Given in every arm · 5 — VAP-cyclo protocol is usual care beside what is tested
- Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's LymphomaCompletedPhase 3German High-Grade Non-Hodgkin's Lymphoma Study GroupNCT00052936Written as CHOP regimen
- SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's LymphomaCompletedPhase 3SWOG Cancer Research NetworkNCT00004031Written as CHOP regimen
- Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's LymphomaCompletedPhase 3NCIC Clinical Trials GroupNCT00064116Written as CHOP regimen
- Treatment of Newly Diagnosed Peripheral T-cell LymphomaStatus unknownPhase 4Zhengzhou UniversityNCT03631862Written as CHOP Regimen
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's LymphomaCompletedPhase 3National Cancer Institute (NCI)NCT00003595Written as CHOP regimen